MedTrace Logo

Pancreatic Endotherapy for Refractory Chronic Pancreatitis

NCT04232670 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2025-09-24

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate whether endoscopic ultrasound (EUS) only versus EUS + endoscopic retrograde cholangiopancreatography (ERCP) with pancreatic endotherapy reduces pain in the treatment of chronic pancreatitis with pancreatic duct obstruction.

Conditions

  • Pancreatic Duct Stone
  • Pancreatic Duct Stricture
  • Pancreatic Duct Dilatation

Interventions

PROCEDURE

EUS + SHAM

Endoscopic Ultrasound

PROCEDURE

EUS + Pancreatic Endotherapy

Pancreatic endotherapy may include any or all of the following maneuvers: pancreatic endoscopic sphincterotomy, stricture dilation using a bougie or hydrostatic balloon catheter, pancreatic stone extraction with or without mechanical or electrohydraulic lithotripsy, extracorporeal shock wave lithotripsy, and stent placement.

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • Gregory Cote, MD, MS · Oregon Health and Science University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-09
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04232670 on ClinicalTrials.gov